New Zealand Health Terminology Service (NZHTS) Implementation Guide
0.1.0 - ci-build
New Zealand Health Terminology Service (NZHTS) Implementation Guide
0.1.0 - ci-build
New Zealand Health Terminology Service (NZHTS) Implementation Guide, published by Health New Zealand | Te Whatu Ora. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/daniel-thomson/nzhts/ and changes regularly. See the Directory of published versions
| Official URL: https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-uveal-tract-site-histology | Version: 0.1.0 | |||
| Active as of 2024-11-11 | Computable Name: canshare-who-uveal-tract-site-histology | |||
| Other Identifiers: http://canshare.co.nz/fhir/NamingSystem/valuesets#canshare-who-uveal-tract-site-histology | ||||
Histologies used for uveal tract sites, from WHO Classification of Tumours, Eye and Orbit Tumours (latest edition) - 4. Tumours of the uveal tract, 10. Haematolymphoid tumours or an 'Other' value.
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
Generated Narrative: ValueSet canshare-who-uveal-tract-site-histology
version: 1; Last updated: 2024-11-05 17:09:02+1300; Language: en-x-sctlang-23162100-0210105
http://snomed.info/sct where constraint = ^ 398771000210106 |New Zealand WHO classification of tumours (5th edition) eye and orbit uveal tract histology reference set| OR ^ 398831000210104 |New Zealand WHO classification of tumours (5th edition) eye and orbit haematolymphoid histology reference set| OR 74964007 |Other|
Generated Narrative: ValueSet canshare-who-uveal-tract-site-histology
version: 1; Last updated: 2024-11-05 17:09:02+1300; Language: en-x-sctlang-23162100-0210105
Expansion based on SNOMED CT 21000210109 edition 01-Oct 2024
This value set contains 22 concepts
| Code | System | Display - English (English, en) |
| 51092000 | http://snomed.info/sct | Chronic lymphocytic leukaemia |
| 1172695008 | http://snomed.info/sct | Diffuse large B cell lymphoma |
| 703711007 | http://snomed.info/sct | Erdheim-Chester disease |
| 397350003 | http://snomed.info/sct | Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue |
| 55150002 | http://snomed.info/sct | Follicular lymphoma |
| 10291008 | http://snomed.info/sct | Giant pigmented naevus |
| 128622001 | http://snomed.info/sct | Histiocytic neoplasm (morphology) |
| 476311000210103 | http://snomed.info/sct | Iris melanoma |
| 128814006 | http://snomed.info/sct | Langerhans cell sarcoma |
| 110450007 | http://snomed.info/sct | Langerhans' cell histiocytosis |
| 314923001 | http://snomed.info/sct | Low grade B-cell lymphoma morphology |
| 397353001 | http://snomed.info/sct | Lymphomatoid papulosis |
| 74654000 | http://snomed.info/sct | Mantle cell lymphoma |
| 35287006 | http://snomed.info/sct | Myeloid sarcoma |
| 128805001 | http://snomed.info/sct | NK/T-cell lymphoma, nasal and nasal-type |
| 74964007 | http://snomed.info/sct | Other |
| 1187107005 | http://snomed.info/sct | Plasmacytoma |
| 128804002 | http://snomed.info/sct | Primary cutaneous CD30 antigen positive T-cell lymphoproliferative disorder |
| 262711000210108 | http://snomed.info/sct | Primary diffuse large B cell lymphoma of vitreoretina |
| 1295376005 | http://snomed.info/sct | Rosai-Dorfman disease |
| 314926009 | http://snomed.info/sct | T-cell lymphoma morphology |
| 466381000210101 | http://snomed.info/sct | Uveal melanoma |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |